Open Label, Randomized, 2 Way-crossover Study to Investigate the Absolute Bioavailability and Pharmacokinetics of RO6811135, Following Single Dose Administration by Subcutaneous and Intravenous Route in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 14 Sep 2015
At a glance
- Drugs RG 7697 (Primary) ; RG 7697 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Roche
- 08 Apr 2014 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 05 Mar 2013 Primary endpoint added as reported by ClinicalTrials.gov.
- 05 Mar 2013 New trial record